Develops advanced molecular diagnostics using whole genome sequencing to detect and monitor blood cancers like multiple myeloma.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Predicta Biosciences develops advanced molecular diagnostic technologies that use whole genome sequencing of cells from blood and bone marrow to provide highly sensitive and comprehensive genomic insights for blood cancers, particularly multiple myeloma. Their GenoPredicta™ platform enables earlier, less invasive, and more informative disease detection and monitoring, supporting precision therapeutic decisions for patients and physicians.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Predicta Biosciences Management Team
Predicta Biosciences Valuations & Financials
View real-time NPM data on Predicta Biosciences stock including daily Predicta Biosciences stock price estimates, valuation history, and historical share price information. Access Predicta Biosciences financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Predicta Biosciences pricing across six independent market signals. Looking for private company due diligence data sources on Predicta Biosciences? Get in touch to learn more.
Similar Companies
like Predicta Biosciences
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Baya Systems
AI & Machine Learning
Advances seamless data flow across chiplets and system‑on‑chip platforms, improving scalability and performance.
Newomics
Healthcare & Life Sciences
Delivers microfluidic chips and multinozzle ionization platforms that enhance sample sensitivity and throughput for mass spectrometry workflows.
OutSystems
Enterprise Software
Offers an AI-powered low-code platform for building, deploying, and managing custom business applications and AI agents.
Agtools
Climate & Sustainability
Delivers analytics that guide market decisions with real‑time agricultural data and trends for improved supply chain insights.
Wayve
Mobility & Transportation
Develops embodied AI software enabling self-driving cars to learn directly from camera data and experience.
Arta Finance
FinTech
Delivers digital wealth management solutions and automated family office investment structures for individuals.
Mind Robotics
AI & Machine Learning
Develops AI‑powered systems which handle complex manufacturing tasks with adaptable intelligence and physical autonomy.
Digio
FinTech
Provides digital transformation solutions including e-signing, document automation, and KYC services for paperless business operations.
FAQ
We have answers
Predicta Biosciences stock does not trade on public stock exchanges. Predicta Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Predicta Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Predicta Biosciences Stock does not trade on public stock exchanges. In order to sell Predicta Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Predicta Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Predicta Biosciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Predicta Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Predicta Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Predicta Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Predicta Biosciences is a private company and has not had an IPO. There is currently no Predicta Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Predicta Biosciences IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
